Galmed Pharmaceuticals
GLMD
#10047
Rank
NZ$8.93 M
Marketcap
$5.39
Share price
-2.24%
Change (1 day)
-22.67%
Change (1 year)

Revenue for Galmed Pharmaceuticals (GLMD)

Revenue in 2024 (TTM): N/A

In 2023 the company made a revenue of N/A a decrease over the revenue in the year 2022 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Galmed Pharmaceuticals from 2013 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A-100%
2018 NZ$3.03 M98.88%
2017 NZ$1.52 M126.6%
2016 NZ$0.67 M
2015 N/A
2014 N/A
2013 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
NZ$7.81 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$3.55 BN/A๐Ÿ‡ฎ๐Ÿ‡ช Ireland
NZ$0.37 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$15.23 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA